Monte Rosa Therapeutics

Switzerland
Breíl, Grisons, Switzerland

Company profile

Monte Rosa Therapeutics company profile

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.

Business identity

Contact email
[email protected]
Phone number
+41 917-363-0113
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
2018-01-01, Year

Headquarters

Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$648.5M
Last funding
Post IPO Equity / $300M / 2026-01-08
Last equity funding
Post IPO Equity / $300M
Investors
14
Lead investors
2
Founders
1
Articles
192
Exited on
2021-06-23

Founders and investors

Founders

Alexander Flohr

Lead investors

Aisling CapitalAvoro Capital Advisors

Investors

Casdin CapitalCormorant Asset ManagementFidelityNew Enterprise AssociatesRTW Investments